News on Knight Scientific Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Knight Scientific Limited news from BioPortfolio.com Wed, 10 Feb 2010 08:54:05 GMT en Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research 2/5/10http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036664&HITNO=0&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036664&THISHREF=http://c.moreover.com/click/here.pl%3fz2536699449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036664&HITNO=0&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036664&THISHREF=http://c.moreover.com/click/here.pl%3fz2536699449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Pharmaceutical Outsourcing: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025351&HITNO=1&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025351&THISHREF=http://c.moreover.com/click/here.pl%3fz2529679762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025351&HITNO=1&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025351&THISHREF=http://c.moreover.com/click/here.pl%3fz2529679762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinancials.com: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023389&HITNO=2&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023389&THISHREF=http://c.moreover.com/click/here.pl%3fz2528196154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023389&HITNO=2&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023389&THISHREF=http://c.moreover.com/click/here.pl%3fz2528196154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Infosys Technologies And Elan Pharmaceuticals Apply Co-Creation Model To Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019619&HITNO=3&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019619&THISHREF=http://c.moreover.com/click/here.pl%3fz2526400715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019619&HITNO=3&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019619&THISHREF=http://c.moreover.com/click/here.pl%3fz2526400715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Infosys Technologies And Elan Pharmaceuticals Apply Co-Creation Model To Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019510&HITNO=4&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019510&THISHREF=http://c.moreover.com/click/here.pl%3fz2526339838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019510&HITNO=4&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019510&THISHREF=http://c.moreover.com/click/here.pl%3fz2526339838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery Online: Elan Pharmaceuticals, Infosys Technologies partner to create comprehensive informatics platform for discovery researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019133&HITNO=5&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019133&THISHREF=http://c.moreover.com/click/here.pl%3fz2526139419%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019133&HITNO=5&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019133&THISHREF=http://c.moreover.com/click/here.pl%3fz2526139419%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015637&HITNO=6&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015637&THISHREF=http://c.moreover.com/click/here.pl%3fz2524460433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015637&HITNO=6&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015637&THISHREF=http://c.moreover.com/click/here.pl%3fz2524460433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016765&HITNO=7&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016765&THISHREF=http://c.moreover.com/click/here.pl%3fz2524872441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016765&HITNO=7&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016765&THISHREF=http://c.moreover.com/click/here.pl%3fz2524872441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIT Backbones: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015442&HITNO=8&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015442&THISHREF=http://c.moreover.com/click/here.pl%3fz2524403401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015442&HITNO=8&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015442&THISHREF=http://c.moreover.com/click/here.pl%3fz2524403401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNW Telbec: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015389&HITNO=9&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015389&THISHREF=http://c.moreover.com/click/here.pl%3fz2524389145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015389&HITNO=9&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015389&THISHREF=http://c.moreover.com/click/here.pl%3fz2524389145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCanada NewsWire: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015278&HITNO=10&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015278&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350377%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015278&HITNO=10&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015278&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350377%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobe Investor: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015269&HITNO=11&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015269&THISHREF=http://c.moreover.com/click/here.pl%3fz2524349450%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015269&HITNO=11&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015269&THISHREF=http://c.moreover.com/click/here.pl%3fz2524349450%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobe Investor: Infosys Technologies and Elan Pharmaceuticals Apply Co-creationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015330&HITNO=12&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015330&THISHREF=http://c.moreover.com/click/here.pl%3fz2524369848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015330&HITNO=12&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015330&THISHREF=http://c.moreover.com/click/here.pl%3fz2524369848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via MSN Money: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015286&HITNO=13&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015286&THISHREF=http://c.moreover.com/click/here.pl%3fz2524353311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015286&HITNO=13&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015286&THISHREF=http://c.moreover.com/click/here.pl%3fz2524353311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015279&HITNO=14&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015279&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015279&HITNO=14&MSIZE=61&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Knight%20Scientific%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015279&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: